250
does orforglipron actually matter or is it forum lore at this point
I have had 9 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied…
u/dario_boateng
Contributes reviews on supplier material. Based in Nantes.
member · joined 14 May 2025
4,151post karma
5,894comment karma
5submissions
57comments
comment on [Seizure] letter arrived, no prosecution, here is exactly what it said in c/customs · 1 points · 3 days ago
the the Netherlands import rules are specific to the Netherlands
comment on [Trial Data] phase 2 biopsy endpoints, and what "resolution" means in c/survodutide · 23 points · 4 days ago
the GLP-1/glucagon dual is hepatic fat, different from GIP/GLP-1
comment on [Speculation] what happens to the research-peptide supply chain if this lands in c/orforglipron · 42 points · 7 days ago
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
comment on [COA] full document, nothing cropped, tell me what i am missing in c/coa · 43 points · 1 months ago
the related substances line is where the story is
comment on [Discussion] we are measuring small molecule at the wrong time and calling it noise in c/orforglipron · 5 points · 1 months ago
Yeah, small molecule changes the whole game.
comment on Germany: water content, and what it actually costs here in c/coa · 54 points · 2 months ago
Yeah, 96.8% area is not the problem, the missing impurity breakdown is the problem.
comment on [PSA] non-peptide is not what most of this community thinks it is in c/orforglipron · 0 points · 2 months ago
oral non-peptide agonist is small molecule, no food restrictions
comment on [Meta] proposal — a flair for certificate of analysis posts in c/coa · 15 points · 3 months ago
PDF metadata is checkable in fifteen seconds
Adding to this: area percent is doing more work than the comment implies.
comment on [Results] 42 weeks, 21kg, and purity was the hard part in c/coa · 1 points · 3 months ago
axis labels included, always
comment on my triglycerides moved and I cannot work out whether small molecule is why in c/orforglipron · 71 points · 3 months ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on COA: what the trials say vs what this community says in c/coa · 1 points · 4 months ago
Water content on the document? That affects your concentration math.
comment on COA: what the trials say vs what this community says in c/coa · 1 points · 4 months ago
You have restated the marketing copy. What is the actual substance here.
comment on [Meta] proposal — a flair for small molecule posts in c/orforglipron · 51 points · 4 months ago
oral non-peptide agonist is oral GLP-1, no food restrictions
comment on biopsy is the most under-discussed thing in c/bloodwork in c/survodutide · 61 points · 4 months ago
phase 11 data is interesting, phase 25 will be different
comment on [Question] import — what am I missing here in c/customs · 63 points · 4 months ago
I am going to push back on this slightly.
comment on why does nobody talk about non-peptide in c/orforglipron · 64 points · 4 months ago
What are you comparing it against though?
comment on [Question] Australia — has anyone got a straight answer on hepatic fat in c/survodutide · 12 points · 4 months ago
the heart rate signal is real in the data
comment on [Question] Australia — has anyone got a straight answer on hepatic fat in c/survodutide · 37 points · 4 months ago
Poland here.
Yes, exactly this, and it is the bit that took me 20 weeks to accept.
comment on stalled for 20 weeks at 1.0mg and I refuse to panic this time in c/coa · -37 points · 5 months ago
This is the correct framing. The COA structure matters as much as the number.